Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Express Scripts
McKesson
Baxter
McKinsey

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. Inventia Healthcare Pvt. Ltd. (D. Del. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Vanda Pharmaceuticals Inc. v. Inventia Healthcare Pvt. Ltd. (D. Del. 2015)

Docket   Start Trial Date Filed 2015-10-13
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties INVENTIA HEALTHCARE PVT. LTD.; VANDA PHARMACEUTICALS INC.
Patents 8,586,610; 9,138,432
Attorneys Daniel J. Klein; Derek James Fahnestock; Eric A. Stone; Ethan Haller Townsend; Jack B. Blumenfeld; Josephine Young; Karen Jacobs; Kira A. Davis; Mary Matterer; Nicholas Groombridge
Firms DLA Piper LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Inventia Healthcare Pvt. Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. Inventia Healthcare Pvt. Ltd. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-10-13 1 infringement of a patent in the same family as the ’432 patent, namely U.S. Patent No. 8,586,610 (“the ’610…Page 2 of 10 PageID #: 2 U.S. Patent No. 9,138,432 (“the ’432 patent”), which relates to the field of…the ’432 patent, or any extensions thereof. Inventia will infringe claim 1 of the ’432 patent under 35… to the methods of the ’432 patent prior to the expiration of that patent, or any extensions thereof.…b) and (c) and 1400(b). IV. THE PATENT-IN-SUIT – U.S. PATENT NO. 9,138,432 14. External link to document
2016-10-05 34 Plaintiffs (Nos. 1-14) directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00921 830 Patent None District Court, D. Delaware External link to document
2016-10-05 35 Plaintiffs (Nos. 1-16) directed to U.S. Patent No. 8,586,610 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00921 830 Patent None District Court, D. Delaware External link to document
2016-10-10 38 Plaintiffs (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00921 830 Patent None District Court, D. Delaware External link to document
2015-10-13 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,138,432;. (sar) (Entered: 10… 13 October 2015 1:15-cv-00921 830 Patent None District Court, D. Delaware External link to document
2016-11-04 50 Interrogatories to Vanda (Nos. 1-16) Directed To U.S. Patent No. 8,586,610 filed by Vanda Pharmaceuticals Inc..(Fahnestock…Interrogatories to Vanda (Nos. 1-14) Directed to U.S. Patent No. 9,138,432 and (2) Vanda's Objections and Responses… 13 October 2015 1:15-cv-00921 830 Patent None District Court, D. Delaware External link to document
2016-11-09 51 Interrogatories to Vanda (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Vanda Pharmaceuticals Inc..(Fahnestock… 13 October 2015 1:15-cv-00921 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
McKesson
Baxter
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.